Cognitive impairment in primary ambulatory health care: Pharmacotherapy and the use of potentially inappropriate medicine

International Journal of Geriatric Psychiatry

Volumn 28, Issue 2, 2013, Pages 173-181

  Fiss, Thomas ^a,b   Thyrian, Jochen René ^a   Fendrich, Konstanze ^b   Van Den Berg, Neeltje ^b   Hoffmann, Wolfgang ^a,b  

^a GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

dementia; drug related problems; health services research; home medication review; potentially inappropriate medication; PRISCUS

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; BROMAZEPAM; BROTIZOLAM; DIAZEPAM; DIMENHYDRINATE; DIMETINDENE; DIPHENHYDRAMINE; DOXEPIN; FLUOXETINE; HALOPERIDOL; LEVOMEPROMAZINE; MAPROTILINE; MEDAZEPAM; NAFTIDROFURYL; NITRAZEPAM; OXYBUTYNIN; PENTOXIFYLLINE; SOLIFENACIN; TEMAZEPAM; THIORIDAZINE; TOLTERODINE; TRIMIPRAMINE; ZOLPIDEM; ZOPICLONE;

AGED; AMBULATORY CARE; ARTICLE; COGNITIVE DEFECT; COHORT ANALYSIS; DEMENTIA; DRUG CONTRAINDICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; MEDICATION THERAPY MANAGEMENT; POLYPHARMACY; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; SCREENING;

AGED; AGED, 80 AND OVER; DEMENTIA; FEMALE; GERMANY; HUMANS; MALE; MEDICATION ERRORS; MULTIVARIATE ANALYSIS; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 84872053829     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.3806     Document Type: Article

References (41)

1. Australian College of Pharmacy Practice. 2001. Comprehensive medication management process-communication and concordance module. In 1-83.
2. Australian Pharmaceutical Advisory Council. 2003. Guidelines for medication management in residential aged care facilities. Canberra.
3. Beers MH,. 1997. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 157 (14): 1531-1536.
4. van den Berg N, Kleinke S, Heymann R, et al,. 2010. Transfer of the AGnES concept to the regular German health-care system: legal evaluation, reimbursement, qualification. Gesundheitswesen 72: 285-292.
5. Bergman A, Olsson J, Carlsten A, Waern M, Fastbom J,. 2007. Evaluation of the quality of drug therapy among elderly patients in nursing homes. Scand J Prim Health Care 25 (1): 9-14.
6. Bjerrum L, Sogaard J, Hallas J, Kragstrup J,. 1998. Polypharmacy: correlations with sex, age and drug regimen. A prescription database study. Eur J Clin Pharmacol 54 (3): 197-202.
7. Cohen J,. 1988. The effect size index: w. In Statistical Power Analysis for the Behavioral Sciences, Lawrence Erlbaum Associates: Hillsdale; 216-226.
8. Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin e.V.(DEGAM). 2008. DEGAM-Leitlinie Nr 12: Demenz. omikron publishing: Düsseldorf.
9. Dhalla IA, Anderson GM, Mamdani MM, et al,. 2002. Inappropriate prescribing before and after nursing home admission. J Am Geriatr Soc 50 (6): 995-1000.
10. Dreier A, Rogalski H, Oppermann RF, et al,. 2010. A curriculum for nurses in Germany undertaking medically-delegated tasks in primary care. J Adv Nurs 66 (3): 635-644.
11. Fick DM, Cooper JW, Wade WE, et al,. 2003. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 163 (22): 2716-2724.
12. Fick DM, Waller JL, Maclean JR, et al,. 2001. Potentially inappropriate medication use in a Medicare managed care population: association with higher costs and utilization. J Manag Care Pharm 7 (5): 407-413.
13. Fiss T, Dreier A, Meinke C, et al,. 2011. Frequency of inappropriate drugs in primary care-analysis of a sample of immobile patients who received periodic home visits. Age Ageing 40 (1): 66-73.
14. Fiss T, Hoffmann W,. 2010. Correspondence (letter to the editor): definition of age. Dtsch Arztebl Int 107 (50): 899-900.
15. Fiss T, Ritter CA, Alte D, van den Berg N, Hoffmann W,. 2010. Detection of drug related problems in an interdisciplinary health care model for rural areas in Germany. Pharm World Sci 32 (5): 566-576.
16. Fortin MP, Rouch I, Dauphinot V, et al,. 2011. Effects of anticholinergic drugs on verbal episodic memory function in the elderly: a retrospective, cross-sectional study. Drugs Aging 28 (3): 195-204.
17. Gallagher P, Baeyens JP, Topinkova E, et al,. 2009. Inter-rater reliability of STOPP (Screening Tool of Older Persons' Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria amongst physicians in six European countries. Age Ageing 38 (5): 603-606.
18. George J, Elliott RA, Stewart DC,. 2008. A systematic review of interventions to improve medication taking in elderly patients prescribed multiple medications. Drugs Aging 25 (4): 307-324.
19. German Association for the Pharmaceutical Industry. 2009. Summary of product characteristics. Available at: www.fachinfo.de, [accessed 1.2.2009].
20. German prescription act. 2009. Federal ministry of justice. Available at: http://www.webcitation.org/5lItqO4WC.
21. Giron MS, Wang HX, Bernsten C, et al,. 2001. The appropriateness of drug use in an older nondemented and demented population. J Am Geriatr Soc 49 (3): 277-283.
22. Glaeske G, Schicktanz C,. 2011. Barmer GEK Arzneimittelreport 2011. Asgard-Verlag: Schwäbisch Gmünd.
23. Grandt D,. 2009. Improving medication safety. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 52: 1161-1165.
24. Gurwitz JH, Field TS, Avorn J, et al,. 2000. Incidence and preventability of adverse drug events in nursing homes. Am J Med 109 (2): 87-94.
25. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X,. 2008. Interventions for enhancing medication adherence. Cochrane Database Syst Rev (2): CD000011. DOI: 10.1002/14651858.CD000011.pub3
26. Hoffmann W, Herzog B, Muhlig S, et al,. 2008. Pharmaceutical care for migraine and headache patients: a community-based, randomized intervention. Ann Pharmacother 42: 1804-1813.
27. Holt S, Schmiedl S, Thürmann PA,. 2010. Potenziell inadäquate medikation für ältere Menschen. Deutsches Aerzteblatt 107 (31-32): 543-551.
28. Jha AK, Doolan D, Grandt D, Scott T, Bates DW,. 2008. The use of health information technology in seven nations. Int J Med Inform 77 (12): 848-854.
29. Kalbe E, Kessler J, Calabrese P, et al,. 2004. DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry 19 (2): 136-143.
30. Lau DT, Mercaldo ND, Harris AT, et al,. 2010. Polypharmacy and potentially inappropriate medication use among community-dwelling elders with dementia. Alzheimer Dis Assoc Disord 24 (1): 56-63.
31. Maidment ID, Fox C, Boustani M, Katona C,. 2011. Medication management-the missing link in dementia interventions. Int J Geriatr Psychiatry. DOI: 10.1002/gps.2745
32. Orwig D, Brandt N, Gruber-Baldini AL,. 2006. Medication management assessment for older adults in the community. Gerontologist 46 (5): 661-668.
33. Poon EG, Wright A, Simon SR, et al,. 2010. Relationship between use of electronic health record features and health care quality: results of a statewide survey. Med Care 48 (3): 203-209.
34. Schaefer M,. 2002. Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc. Pharm World Sci 24 (4): 120-127.
35. Schulz M, Verheyen F, Muhlig S, et al,. 2001. Pharmaceutical care services for asthma patients: a controlled intervention study. J Clin Pharmacol 41 (6): 668-676.
36. Schwalbe O, Freiberg I, Kloft C,. 2007. Die Beers-Liste: ein instrument zur optimierung der arzneimitteltherapie geriatrischer patienten. Med Monatsschr Pharm 30 (7): 244-248.
37. Somers M, Rose E, Simmonds D, et al,. 2010. Quality use of medicines in residential aged care. Aust Fam Physician 39 (6): 413-416.
38. Sorensen L, Stokes JA, Purdie DM, Woodward M, Roberts MS,. 2006. Medication management at home: medication risk factor prevalence and inter-relationships. J Clin Pharm Ther 31 (5): 485-491.
39. WIDO-Wissenschaftliches Institut der AOK. 2007. ATC/DDD-ROM 2007-Anatomisch-therapeutisch-chemische Klassifikation mit Tagesdosen für den deutschen Arzneimittelmarkt. In Wissenschaftliches Institut der AOK (WIdO), CD-ROM, Bonn.
40. Winterstein A, Schaefer M, Jopp R,. 2001. OMA-STUDIE: Patienten profitieren von der Pharmazeutischen Betreuung. Pharm Ztg 11 (13). Available at: http://www.pharmazeutische-zeitung.de/index.php?id=22497.
41. Zuckerman IH, Hernandez JJ, Gruber-Baldini AL, et al,. 2005. Potentially inappropriate prescribing before and after nursing home admission among patients with and without dementia. Am J Geriatr Pharmacother 3 (4): 246-254.